Fox Run Management L.L.C. acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent filing with the SEC. The firm acquired 16,000 shares of the pharmacy operator’s stock, valued at approximately $1,253,000. Walgreens Boots Alliance comprises about 0.4% of Fox Run Management L.L.C.’s holdings, making the stock its 14th largest position.
A number of other large investors have also recently bought and sold shares of WBA. Waldron LP grew its position in Walgreens Boots Alliance by 67.7% in the 1st quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock valued at $373,000 after buying an additional 1,816 shares during the last quarter. Founders Capital Management LLC grew its position in Walgreens Boots Alliance by 1.7% in the 1st quarter. Founders Capital Management LLC now owns 71,991 shares of the pharmacy operator’s stock valued at $5,979,000 after buying an additional 1,180 shares during the last quarter. Acadian Asset Management LLC grew its position in Walgreens Boots Alliance by 17.6% in the 1st quarter. Acadian Asset Management LLC now owns 31,082 shares of the pharmacy operator’s stock valued at $2,582,000 after buying an additional 4,653 shares during the last quarter. First Citizens Bank & Trust Co. purchased a new position in Walgreens Boots Alliance in the 1st quarter valued at $4,763,000. Finally, AMI Investment Management Inc. grew its position in Walgreens Boots Alliance by 160.6% in the 1st quarter. AMI Investment Management Inc. now owns 7,323 shares of the pharmacy operator’s stock valued at $433,000 after buying an additional 4,513 shares during the last quarter. Hedge funds and other institutional investors own 60.18% of the company’s stock.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.60% on Friday, hitting $82.50. The stock had a trading volume of 22,167,526 shares. The company has a market cap of $88.28 billion, a PE ratio of 20.83 and a beta of 1.26. The stock has a 50-day moving average of $81.26 and a 200-day moving average of $81.99. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter last year, the business posted $1.18 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its Board of Directors has authorized a stock buyback plan on Thursday, June 29th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.94%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 40.30%.
A number of equities analysts recently weighed in on the stock. Needham & Company LLC set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a $77.00 price objective (down from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $91.81.
TRADEMARK VIOLATION NOTICE: This report was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://transcriptdaily.com/2017/09/16/fox-run-management-l-l-c-acquires-shares-of-16000-walgreens-boots-alliance-inc-wba.html.
In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.